Deals of the day-Mergers and acquisitions – 04/11/2024 at 3:40 p.m.


((Automated translation by Reuters, please see disclaimer https://bit.ly/rtrsauto))

(Additions: GeoPark updates: Novartis, Société Générale)

The following deals, mergers, acquisitions and divestitures were reported at 1330 GMT on Thursday:

** Novartis NOVN.S said it had launched a tender offer to acquire MorphoSys MORG.DE, a German developer of cancer treatments, for a total consideration of 2.70 billion euros ($2.90 billion). dollars).

** Latin American oil and gas producer GeoPark GPRK.N said it has submitted a binding offer to acquire an unoperated operating interest in unconventional blocks in Argentina’s Neuquen Basin from a anonymous seller.

** Societe Generale SOGN.PA said it agreed to sell its professional equipment financing business to French rival BPCE for 1.10 billion euros ($1.20 billion) as part of a strategy to broader divestment, which sent its shares up more than 3%.

** Blackstone BX.N and CVC are among a list of potential bidders for European festival organizer Superstruct Entertainment, several sources with knowledge of the situation told Reuters.

** Rhone Energies, a consortium of commodities trader Trafigura and Entara LLC, is in exclusive negotiations with Exxon Mobil’s ESSO SAF ESSF.PA to acquire the Fos-sur-Mer refinery in the south of France and the Toulouse and Villette de Vienne terminals.

** European self-storage company Shurgard SHUR.BR agreed to buy British rival Lok’nStore LOK.L in a cash deal worth 378 million pounds ($474 million ) to expand into markets beyond London, the companies said in a joint statement.

** The US Justice Department has opened an in-depth antitrust investigation into Nippon Steel 5401.T’s $14.1 billion takeover of US Steel XN, Politico reported on Wednesday, citing two people with direct knowledge of the deal. ‘affair.

** Vertex Pharmaceuticals VRTX.O will buy Alpine Immune Sciences ALPN.O for about $4.9 billion in cash, gaining access to the biotech company’s treatment for an autoimmune kidney disease, the companies said Wednesday.



Source link -86